Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

NCT01324635 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Arm A - reached goal; Arm B - poor accrual

Conditions

Recurrent Glioma
High-grade Meningioma
Brain Metastasis

Interventions

DRUG: Panobinostat
RADIATION: Stereotactic body radiation therapy
PROCEDURE: Quality-of-life assessment
RADIATION: Stereotactic radiosurgery

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]